Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II/III trial of recombinant human follicle-stimulating hormone-CTP fusion protein in women undergoing ART
ChiCTR2000038030Phase 2Recruiting
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Sep 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of corifollitropin alfa and follitropin alfa in female infertility (2 arms), sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoints: Number of oocytes retrieved and Safety evaluation. Started Sep 2019; status: recruiting.
02
Drugs
corifollitropin alfafollitropin alfa
03
Conditions
female infertility
Beyond the preview
Go deeper on ChiCTR2000038030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038030.